GoodRx Statistics
Share Statistics
GoodRx has 381.14M shares outstanding. The number of shares has increased by 310.66% in one year.
| Shares Outstanding | 381.14M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 1.13% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 313.64M |
| Failed to Deliver (FTD) Shares | 165.12K |
| FTD / Avg. Volume | 12.49% |
Short Selling Information
The latest short interest is 8.69M, so 2.28% of the outstanding shares have been sold short.
| Short Interest | 8.69M |
| Short % of Shares Out | 2.28% |
| Short % of Float | 2.77% |
| Short Ratio (days to cover) | 10.07 |
Valuation Ratios
The PE ratio is -310 and the forward PE ratio is 11.46.
| PE Ratio | -310 |
| Forward PE | 11.46 |
| PS Ratio | 3.66 |
| Forward PS | 2 |
| PB Ratio | 3.61 |
| P/FCF Ratio | 33.31 |
| PEG Ratio | n/a |
Enterprise Valuation
GoodRx Inc. has an Enterprise Value (EV) of 2.79B.
| EV / Earnings | -314.38 |
| EV / Sales | 3.72 |
| EV / EBITDA | 24.69 |
| EV / EBIT | -103.23 |
| EV / FCF | 33.78 |
Financial Position
The company has a current ratio of 7.12, with a Debt / Equity ratio of 0.87.
| Current Ratio | 7.12 |
| Quick Ratio | 7.12 |
| Debt / Equity | 0.87 |
| Total Debt / Capitalization | 46.52 |
| Cash Flow / Debt | 0.21 |
| Interest Coverage | -0.48 |
Financial Efficiency
Return on equity (ROE) is -0.01% and return on capital (ROIC) is -0.29%.
| Return on Equity (ROE) | -0.01% |
| Return on Assets (ROA) | -0.01% |
| Return on Capital (ROIC) | -0.29% |
| Revenue Per Employee | 1.08M |
| Profits Per Employee | -12.78K |
| Employee Count | 694 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | -46.70M |
| Effective Tax Rate | 0.84 |
Stock Price Statistics
The stock price has increased by -25.59% in the last 52 weeks. The beta is 1.39, so GoodRx 's price volatility has been higher than the market average.
| Beta | 1.39 |
| 52-Week Price Change | -25.59% |
| 50-Day Moving Average | 5.67 |
| 200-Day Moving Average | 7.09 |
| Relative Strength Index (RSI) | 38.18 |
| Average Volume (20 Days) | 1.32M |
Income Statement
In the last 12 months, GoodRx had revenue of $750.26M and earned -$8.87M in profits. Earnings per share was $-0.02.
| Revenue | 750.26M |
| Gross Profit | 683.34M |
| Operating Income | -27.01M |
| Net Income | -8.87M |
| EBITDA | 112.93M |
| EBIT | -27.01M |
| Earnings Per Share (EPS) | -0.02 |
Balance Sheet
The company has $672.30M in cash and $711.07M in debt, giving a net cash position of -$38.77M.
| Cash & Cash Equivalents | 672.30M |
| Total Debt | 711.07M |
| Net Cash | -38.77M |
| Retained Earnings | -1.46B |
| Total Assets | 1.35B |
| Working Capital | 512.44M |
Cash Flow
In the last 12 months, operating cash flow was $138.29M and capital expenditures -$55.77M, giving a free cash flow of $82.53M.
| Operating Cash Flow | 138.29M |
| Capital Expenditures | -55.77M |
| Free Cash Flow | 82.53M |
| FCF Per Share | 0.2 |
Margins
Gross margin is 91.08%, with operating and profit margins of -3.6% and -1.18%.
| Gross Margin | 91.08% |
| Operating Margin | -3.6% |
| Pretax Margin | -7.41% |
| Profit Margin | -1.18% |
| EBITDA Margin | 15.05% |
| EBIT Margin | -3.6% |
| FCF Margin | 11% |
Dividends & Yields
GDRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -0.42% |
| FCF Yield | 4.6% |
Analyst Forecast
The average price target for GDRX is $8.5, which is 80.5% higher than the current price. The consensus rating is "Buy".
| Price Target | $8.5 |
| Price Target Difference | 80.5% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
Scores
| Altman Z-Score | 1.3 |
| Piotroski F-Score | 6 |